Sept. 17, 2025 — Barbara Riegel, Ph.D., R.N., FAHA, Emerita Edith Clemmer Steinbright Professor of Gerontology at the University of Pennsylvania School of Nursing, will receive the American Heart Association’s 2025 Clinical Research Prize at the Association’s Scientific Sessions 2025. The meeting, taking place Nov. 7-10, 2025, in New Orleans is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. Dr. Riegel will be awarded during the Presidential Session on Sunday, Nov. 9, 2025.

Sept. 16, 2025 — PaceMate has appointed Sean Shoffstall as Head of AI, Innovation and Data Strategy. Shoffstall joins PaceMate after holding senior roles with Beginly Health, Welby Health and Auditdata, where he played an integral part in the launch of the first HIPAA-compliant AI-generated audiogram analysis tool in the industry.

Sept. 11, 2025 — Newswise —  A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women — are caused by factors other than clogged arteries, challenging long-standing assumptions about how heart attacks occur in younger populations.

Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, will present 30-day results of its POWER PAD II U.S. pivotal trial for Pulsatile Intravascular Lithotripsy (PIVL) therapy as a Late Breaking Clinical Trial (LBCT) at the Vascular InterVentional Advances (VIVA) meeting in November in Las Vegas.

Digital Tools Provide Insight into AFib

Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable way to predict who will develop it or when. Unlike conditions such as coronary disease, where biomarkers like high cholesterol provide early warning signs and treatment options, AFib lacks a definitive predictor.

Sept. 2, 2025 — Although cardiovascular disease is a leading cause of death for women, they remain underrepresented in clinical trials for common heart conditions. These findings, by investigators in the Smidt Heart Institute at Cedars-Sinai, were presented at the 2025 European Society of Cardiology Congress in Madrid.

Sept. 9, 2025 — The John Ritter Foundation for Aortic Health, a nonprofit dedicated to raising awareness, advancing research and providing education on thoracic aortic disease to prevent premature deaths, has released an updated Ritter Rules, a set of clear guidelines designed to promote early detection, empower patients, and improve outcomes.

Sept. 9, 2025 — The American Venous Forum (AVF), International Society on Thrombosis and Haemostasis (ISTH), National Blood Clot Alliance (NBCA), Penumbra, the PERT Consortium and Society for Vascular Medicine (SVM) have come together to form the Get Out the Clot campaign. The groups have announced findings from a new survey assessing the current state of venous thromboembolism (VTE) care (blood clots).

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Revolution Vibe CT system, an innovative imaging solution designed to elevate coronary CT angiography (CCTA). With Unlimited One-Beat Cardiac imaging and integrated AI-powered tools, Revolution Vibe offers clinicians a fast, powerful, and non-invasive way to identify potential heart blockages while enhancing patient comfort and streamlining workflow.

Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology (JACC), showcasing real-world clinical applications of the CorVista System, a non-invasive, point-of-care diagnostic test for pulmonary hypertension (PH).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now